Navigation Links
Can a virtual brain replace lab rats?

Testing the effects of drugs on a simulated brain could lead to breakthrough treatments for neurological disorders such as Parkinson's, Huntington's and Alzheimer's disease.

Researchers from the University of Waterloo in Canada hope Spaun, the world's largest functioning model of the brain, will be used to test new drugs that lead to medical breakthroughs for brain disorders.

Terrence Stewart, a post-doctoral researcher with the Centre for Theoretical Neuroscience at Waterloo and project manager for Spaun, will tell an audience at the American Association for the Advancement of Science (AAAS) annual meeting in Chicago about the advantages of using whole-brain simulation as a tool to aid new discoveries in medicine.

"Our hope is that you could try out different possible treatments quickly to see how the brain reacts and how each one changes behaviour before testing them in people," said Stewart. "Our brain model offers a new way to test treatments. For Alzheimer's disease or a stroke that causes memory loss, we could see how a new drug affects the firing pattern of individual brain cells and measure how it changes brain performance on memory tests before trying it on people."

Stewart's team has already made progress simulating Parkinson's and Huntington's diseases. Their next step is to simulate Alzheimer's disease after giving Spaun a hippocampus, the brain region involved in forming new memories.

Spaun is more like the human brain than other computer brain models because it makes mistakes and loses abilities in similar ways to people. To simulate the cognitive decline associated with aging, for example, Stewart and his team killed off neurons in the brain model and observed it gradually forgetting more numbers on a memory test.

To reproduce movement problems associated with Huntington's disease and damage to the cerebellum, Stewart damaged parts of the simulated brain affected by those conditions.

"We showed that errors made in reaching behaviour seen in people with those disorders correspond to the errors made by our brain model when neurons in the affected brain regions are damaged," he said.

Spaun can see, remember, think and write using a mechanical arm. Most importantly, this virtual brain which mimics the neuron firing patterns seen in the human brain allows the researchers to study and understand how damage to individual cells affects the behaviour of the whole brain in different neurological diseases.


Contact: Nick Manning
University of Waterloo

Related biology news :

1. Researchers hit virtual heads to make safer games
2. Virtual skin model reveals secrets of skin aging
3. Amazon River exhales virtually all carbon taken up by rain forest
4. Virtual patient advocate delivers preconception care to improve pregnancy outcomes
5. Virtual, squishy creatures evolve to run using evolutionary algorithms
6. Virtual vehicle vibrations
7. UT Dallas researchers pushing the boundaries of virtual reality
8. Virtual women reveal more skin, regardless of body proportions
9. U of M to lead international virtual institute studying climatic and human effects on Earth
10. VirtualScopics Schedules Third Quarter 2012 Earnings Announcement
11. University of Tennessee Space Institute researchers make clinical trials a virtual reality
Post Your Comments:
(Date:11/19/2015)... -- Although some 350 companies are actively involved in molecular ... according to Kalorama Information. These include Roche Diagnostics, Hologic, Abbott ... of the 6.1 billion-dollar molecular testing market, according to ... Diagnostic s .    ... one company and only a handful of companies can ...
(Date:11/17/2015)... , November 17, 2015 ... 19 novembre  2015.  --> Paris , ... --> DERMALOG, le leader de l,innovation biométrique, a ... fois passeports et empreintes sur la même surface de ... passeports et l,autre pour les empreintes digitales. Désormais, un ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015  Twist Bioscience, ... that Emily Leproust, Ph.D., Twist Bioscience chief executive ... Healthcare Conference on December 1, 2015 at 3:10 ... in New York City. --> ... . Twist Bioscience is on Twitter. Sign ...
(Date:11/24/2015)... BC (PRWEB) , ... November 24, 2015 , ... ... our customer, OrthoAccel® Technologies, Inc., on being named to Deloitte's 2015 Technology Fast ... Technologies’ Texas facility, OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device that ...
(Date:11/24/2015)... HemoShear Therapeutics, LLC, a privately held ... disorders, announced today the appointment of H. ... (BOD). Mr. Watkins is the former president and ... and also served as the chairman of the ... Chairman and CEO of HemoShear Therapeutics. "The combination ...
(Date:11/24/2015)... ... ... Laboratories is pleased to announce that it has completed construction on a new ... 61, USP 62 and USP 51 testing specific to raw materials and will enable ... by one supplier. Management has formally announced that the facility will be ...
Breaking Biology Technology: